Abstract
Encouraged by bacteremia clearance using antistaphylococcal beta-lactams plus carbapenem combination in adults with refractory methicillin-sensitive Staphylococcus aureus infection, we present our experience with 2 preterm infants and review 1 previously published case. Noted successful bacteremia clearance in all 3 must be weighed against possible adverse effects associated with carbapenem use.
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
MeSH terms
-
Anti-Bacterial Agents* / administration & dosage
-
Anti-Bacterial Agents* / adverse effects
-
Anti-Bacterial Agents* / therapeutic use
-
Bacteremia* / drug therapy
-
Bacteremia* / microbiology
-
Carbapenems* / therapeutic use
-
Cefazolin* / therapeutic use
-
Drug Therapy, Combination
-
Humans
-
Infant, Newborn
-
Infant, Premature*
-
Staphylococcal Infections* / drug therapy
-
Staphylococcal Infections* / microbiology
-
Staphylococcus aureus* / drug effects
-
Treatment Outcome
Substances
-
Anti-Bacterial Agents
-
Carbapenems
-
Cefazolin